Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: A technical note

AAPS PharmSciTech

Volumn 8, Issue 1, 2007, Pages

  Gohel, Mukesh C ^a   Parikh, Rajesh K ^a   Brahmbhatt, Bansari K ^a   Shah, Aarohi R ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Coprocessing by dry granulation; Croscarmellose sodium; Crospovidone; Dissolution enhancement; Ibuprofen

Indexed keywords

CROSCARMELLOSE SODIUM; CROSPOVIDONE; DISINTEGRATING AGENT; IBUPROFEN; DRUG CARRIER; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTROLLED STUDY; CRUSHING STRENGTH; DRUG SOLUBILITY; FEASIBILITY STUDY; PARTICLE SIZE; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET THICKNESS; WETTABILITY; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG FORMULATION; DRUG SCREENING; EVALUATION; MATERIALS TESTING; METHODOLOGY; SOLUBILITY; TABLET;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; IBUPROFEN; MATERIALS TESTING; PARTICLE SIZE; SOLUBILITY; TABLETS;

EID: 33847405438     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0801001     Document Type: Article

References (15)

1. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practice, of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986:293-345.
2. Shangraw R, Mitrevej A, Shah M. A new era of tablet disintegrants. Pharm Technol. 1980;4:49-57.
3. Zhao N, Augusburger L. The influence of swelling capacity of superdisintegrants in different pH media on dissolution of hydrochlorthiazide from directly compressed tablets. AAPS PharmSciTech. 2005;6: E120-E126. serial online.
4. Pharmaceutical Products. International Specialty Products Web site. Available at: http://www.ispcorp.com/products/pharma/content/brochure/ polycros. Accessed May 10, 2006.
5. Biopolymer-Pharmaceuticals-Disintegrants. FMC Corporation Web site. Available at: http://www.fmcbiopolymer.com/Pharmaceuticals/ Disintegrants/tabid/503/Default.aspx. Accessed February 7, 2007.
6. Pharmacopeia US. USP 29-NF 24. Rockville, MD: USP; 2005.
7. Gohel MC, Patel SD, Shah NK, Jani GK. Evaluation of synthesized cross-linked tragacanth as a potential disintegrant. Indian J Pharm Sci. 1996;59:113-118.
8. Thibert R, Hancock BC. Direct visualization of superdisintegrant hydration using environmental scanning electron microscopy. J Pharm Sci 1996;85:1255-1258.
9. Rudnic E. Oral solid dosage forms. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy Volume II. 19th ed. Easton, PA: Mack Publishing Company; 1995:1615-1649.
10. Alderborn G, Nystrom C. Pharmaceutical Powder Compaction Technology. New York, NY. Marcel Dekker, 1996.
11. He X, Kibbe AH. Crospovidone. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003:108-111.
12. Gohel MC, Jogani PD, Bariya SH. Development of agglomerated directly compressible diluents consisting of brittle and ductile materials. Pharm Dev Technol. 2003;8:143-151.
13. Marshall PV, Pope DG, Carstensen JT. Methods for the assessment of the stability of tablet disintegrants. J Pharm Sci. 1991;80:899-903.
14. Gordon MS. Rudraraju VS, Kaushik D, Chhowhan ZT. Effect of mode of superdisintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci. 1993;82:220-226.
15. Mishra DN, Bindal M, Singh SK, Vijaya Kumar GV. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull (Tokyo). 2006;54:99-102.